- Home
- HCAI vs ALLR Comparison
HCAI vs ALLR Comparison
Compare HCAI & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCAI
- ALLR
- Stock Information
- Founded
- HCAI 2004
- ALLR 2004
- Country
- HCAI China
- ALLR United States
- Employees
- HCAI N/A
- ALLR N/A
- Industry
- HCAI Miscellaneous manufacturing industries
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- HCAI Consumer Discretionary
- ALLR Health Care
- Exchange
- HCAI Nasdaq
- ALLR Nasdaq
- Market Cap
- HCAI 20.3M
- ALLR 20.2M
- IPO Year
- HCAI 2025
- ALLR N/A
- Fundamental
- Price
- HCAI $0.36
- ALLR $1.30
- Analyst Decision
- HCAI
- ALLR Strong Buy
- Analyst Count
- HCAI 0
- ALLR 1
- Target Price
- HCAI N/A
- ALLR $9.25
- AVG Volume (30 Days)
- HCAI 75.0K
- ALLR 203.6K
- Earning Date
- HCAI 12-19-2025
- ALLR 11-14-2025
- Dividend Yield
- HCAI N/A
- ALLR N/A
- EPS Growth
- HCAI N/A
- ALLR N/A
- EPS
- HCAI 0.00
- ALLR N/A
- Revenue
- HCAI $19,176,987.00
- ALLR N/A
- Revenue This Year
- HCAI N/A
- ALLR N/A
- Revenue Next Year
- HCAI N/A
- ALLR N/A
- P/E Ratio
- HCAI $105.36
- ALLR N/A
- Revenue Growth
- HCAI N/A
- ALLR N/A
- 52 Week Low
- HCAI $0.35
- ALLR $0.61
- 52 Week High
- HCAI $10.97
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- HCAI 28.19
- ALLR 53.02
- Support Level
- HCAI $0.36
- ALLR $0.99
- Resistance Level
- HCAI $0.41
- ALLR $1.17
- Average True Range (ATR)
- HCAI 0.05
- ALLR 0.10
- MACD
- HCAI -0.01
- ALLR 0.02
- Stochastic Oscillator
- HCAI 3.67
- ALLR 93.89
About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares
Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.